| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/14/2008 | CN101177487A Thermo-sensitive biodegradable polyanhydride copolymer as well as aquogel system and uses thereof |
| 05/14/2008 | CN101177482A Alpha, beta-poly(L- aspartate)-aminophenol derivatives and preparation thereof |
| 05/14/2008 | CN101177456A Modified transferrin fusion proteins |
| 05/14/2008 | CN101177455A Modified transferrin fusion proteins |
| 05/14/2008 | CN101176791A Amino acid communicating with polyglycol as well as manufacturing method and usage thereof |
| 05/14/2008 | CN101176790A Percutaneous absorption fortifier |
| 05/14/2008 | CN101176789A Method for preparing temperature sensitive sustained-release gel of chitosan fat complexes |
| 05/14/2008 | CN101176787A Method for chemoprevention of prostate cancer |
| 05/14/2008 | CN101176785A Regrouping bi-functional leech essence oral preparation and preparation method thereof |
| 05/14/2008 | CN101176774A Preparations capable of accelerating somnus and improving somnus quality as well as preparation method thereof |
| 05/14/2008 | CN101176749A Chaihuang freeze dried injection and preparation method thereof |
| 05/14/2008 | CN101176741A Hydroxypropyl-beta-cyclodextrin clathrate, preparing method and application of radix bupleuri volatile oil |
| 05/14/2008 | CN101176732A Hydrochloric acid glucosamine dispersible tablet and preparation method thereof |
| 05/14/2008 | CN101176729A Huperzine dropping pills and preparation method thereof |
| 05/14/2008 | CN101176726A Medicine-loading sustained-release micro-capsule and preparing method thereof |
| 05/14/2008 | CN101176723A Ranolazine sustained release tablets |
| 05/14/2008 | CN101176722A Scutellaria glycosides freeze dried injection solution and preparation method thereof |
| 05/14/2008 | CN101176721A Hexamethylmelamine liposome and preparation method thereof |
| 05/14/2008 | CN101176720A Ligustrazine microcosmic salt liposome medicine and preparing method |
| 05/14/2008 | CN101176717A Temperature control gel rubber sustained-release injection containing resist metabolism series medicine |
| 05/14/2008 | CN101176716A Sunitinib sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176715A Gefitinib sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176714A Meifaron sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176713A Carmustine sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176712A Nimustine sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176711A Yitarbisin sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176710A Mitoxantrone sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176709A Beisalutin sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176708A Carmofur sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176707A Carmustine sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176706A Temperature control sustained-release injection containing resist metabolism series medicine |
| 05/14/2008 | CN101176567A Coating for oxygen sensitive materials |
| 05/14/2008 | CN100387616C Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/14/2008 | CN100387312C Method for injecting solid mater into hypodermis |
| 05/14/2008 | CN100387302C Folacin-starch nanometer granule, its preparation method and application |
| 05/14/2008 | CN100387230C Pharmaceutical combination prepared by cannabis extract |
| 05/14/2008 | CN100387228C Injectable methadone, partial opioid-opium agonist or opioid-opium antagonist particle composition, and use thereof |
| 05/14/2008 | CN100387227C Thin aqueous cataplasm material |
| 05/14/2008 | CN100387222C Solid preparation for dialysis and process for producing the same |
| 05/13/2008 | US7371829 Haptens, immunogens, antibodies and conjugates to ketamine and its metabolites |
| 05/13/2008 | US7371781 Tumor environment-induced ligand-expressing nanocarrier system |
| 05/13/2008 | US7371744 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371722 Pharmaceutical preparations and medicine capable of generating and/or containing thrombin |
| 05/13/2008 | US7371572 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection |
| 05/13/2008 | US7371543 Factor VII or VIIa-like molecules |
| 05/13/2008 | US7371411 oxidized glutathione-based compound having a stabilized disulfide bond |
| 05/13/2008 | US7371407 the oil is used as a carrying agent for anti-microbial formulations; comprises terbinafine and other antibiotics; for topical application to the skin or mucosal membranes of a mammal |
| 05/13/2008 | US7371406 for needles comprising time release microparticles containing risperidones, glycolic acid-lactic acid copolymer binders, and high viscosity aqueous fluids (containing sodium carboxymethyl cellulose as modifier) |
| 05/13/2008 | US7371405 Liquid matrix containing drug, a first flavoring agent, and a plurality of particles comprising a second flavoring agent; adjusted color, flavor, sweetness, texture |
| 05/13/2008 | US7371404 Amphoteric liposomes and their use |
| 05/13/2008 | US7371402 Calcium sensitive pectins provide high yield stress characteristics to aqueous composition without gelation |
| 05/13/2008 | US7371373 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 05/13/2008 | US7371069 Manikin and eye device apparatus, methods and articles of manufacture |
| 05/13/2008 | CA2438169C Modulated release particles for aerosol delivery |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2409292C Tablets and methods for modified release of hydrophilic and other active agents |
| 05/13/2008 | CA2394980C Sterically hindered derivatives of water soluble polymers |
| 05/13/2008 | CA2378490C Antibiotic/antibiotics (or: antibiotic(s)) preparation with retarding active ingredient release |
| 05/13/2008 | CA2283326C An aqueous metal bicarbonate solution and method of use |
| 05/13/2008 | CA2223438C Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 05/13/2008 | CA2216658C Hapten-carrier conjugates for use in drug-abuse therapy |
| 05/13/2008 | CA2125855C A stabilized pharmaceutical formulation comprising growth hormone and histidine |
| 05/08/2008 | WO2008054544A2 Method for delivery across the blood brain barrier |
| 05/08/2008 | WO2008054498A2 Hydrophilic polymer-conjugated lipids for peptide and protein folding disorders |
| 05/08/2008 | WO2008054081A1 Hyaluronic acid and hydrophobic poly amino acid copolymer |
| 05/08/2008 | WO2008053988A1 Method of producing microcapsules |
| 05/08/2008 | WO2008053983A1 Composition for iontophoresis for delivery through hair pore |
| 05/08/2008 | WO2008053942A1 Composition for throat |
| 05/08/2008 | WO2008053920A1 Physiologically active substance-containing granular composition and method of producing the same |
| 05/08/2008 | WO2008053799A1 W/o/w emulsion composition |
| 05/08/2008 | WO2008053479A1 Self-immolative polymers |
| 05/08/2008 | WO2008053388A1 Appliance for delivering a composition, the appliance having an elastic layer and a shielding layer |
| 05/08/2008 | WO2008053387A1 Appliance for delivering a composition, the appliance having an outer fibrous layer and inner liquid-impermeable layer |
| 05/08/2008 | WO2008053250A2 Formulations for delivery via pressurised metered dose inhalers comprising an essential oil as suspension stabiliser |
| 05/08/2008 | WO2008052912A1 Antimicrobially active composition having a content of bispyridinium alkane (octenidine dihydrochloride) |
| 05/08/2008 | WO2008052679A2 Use of a fusion protein between a cytokine and an antibody targeting the ed-b fibronectin domain for the treatment of atherosclerosis |
| 05/08/2008 | WO2008052350A1 Photodynamic therapy for the treatment of hidradenitis suppurativa |
| 05/08/2008 | WO2008052323A1 Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infection |
| 05/08/2008 | WO2008052322A1 Immunotoxγn fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers |
| 05/08/2008 | WO2008052295A1 Process for the preparation of compounds of at1 receptor antagonists with angiotensin-(1-7), analogues thereof and/or mixtures of these systems, pharmaceutical compositions thereof and use of their derivative products |
| 05/08/2008 | WO2008052294A1 Preparation of compounds of cyclodextrins and derivatives thereof with bismuth compounds |
| 05/08/2008 | WO2008052263A1 Delivery system for remote treatment of an animal |
| 05/08/2008 | WO2008033058A3 Method for producing insulin in the form of an oral preparation |
| 05/08/2008 | WO2008025819A3 Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability |
| 05/08/2008 | WO2008021795A3 Flowable carrier matrix |
| 05/08/2008 | WO2008015415A3 Asymmetric fluoro-substituted polymethine dyes |
| 05/08/2008 | WO2008015099A3 Pegylated, extended insulins |
| 05/08/2008 | WO2008005240A3 Ropinirole-containing pharmaceutical compositions in the form of a gel, uses thereof |
| 05/08/2008 | WO2007141182A3 Utilization of vinyl acetate sulfonate copolymers as solubilizers for compounds with low solubility in water |
| 05/08/2008 | WO2007103348A3 Process for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants |
| 05/08/2008 | WO2007098033A3 Feedback prodrug |
| 05/08/2008 | WO2007095041A3 Pharmaceutical formulations |
| 05/08/2008 | WO2007095039A3 Pharmaceutical formulations |
| 05/08/2008 | WO2007072216A3 Kit and composition of imidazole with enhanced bioavailability |
| 05/08/2008 | WO2007014672A3 Hydrogel |
| 05/08/2008 | US20080108797 Modified Human Growth Hormone Polypeptides and Their Uses |
| 05/08/2008 | US20080108791 Modified Human Interferon Polypeptides and Their Uses |
| 05/08/2008 | US20080108713 identifying an individual who has an altered risk for developing psoriasis; medcal diagnosis and analysis; detecting a SNP haplotype; drug screening; treatment with biodrugs |
| 05/08/2008 | US20080108712 diagnosing and/or treating patients that either have or are at risk for developing cardiovascular disorders; diabetic patient or on hormone replacement therapy; biodrugs; determining the identity of the nucleotide at position -54,642 of a nucleotide sequence; microarrays |